ASX - By Stock
|
PLS |
Re:
Ann: FY22 Annual Financial Results Announcement
|
|
snowunda
|
122 |
94K |
30 |
23/08/22 |
23/08/22 |
ASX - By Stock
|
122
|
94K
|
30
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Clinical utility study shows benefit of PromarkerD testing
|
|
snowunda
|
17 |
6.0K |
9 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
17
|
6.0K
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics contracts Biotem to manufacture PromarkerD kits
|
|
snowunda
|
12 |
4.2K |
8 |
12/08/21 |
12/08/21 |
ASX - By Stock
|
12
|
4.2K
|
8
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Conference presentation - Australasian Diabetes Congress 202
|
|
snowunda
|
4 |
1.8K |
1 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
4
|
1.8K
|
1
|
|
ASX - By Stock
|
SE1 |
Re:
Break even
|
|
snowunda
|
30 |
7.0K |
10 |
26/07/21 |
26/07/21 |
ASX - By Stock
|
30
|
7.0K
|
10
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Suspension from Official Quotation
|
|
snowunda
|
80 |
22K |
10 |
30/06/21 |
30/06/21 |
ASX - By Stock
|
80
|
22K
|
10
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: ISO 13485 certification received - Manufacturing Update
|
|
snowunda
|
19 |
5.7K |
1 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
19
|
5.7K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Exercise of Options
|
|
snowunda
|
57 |
19K |
1 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
57
|
19K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Exercise of Options
|
|
snowunda
|
57 |
19K |
1 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
57
|
19K
|
1
|
|
ASX - By Stock
|
AVL |
Re:
Ann: ESG Consultant Appointed to Map Sustainability Pathway
|
|
snowunda
|
25 |
10K |
28 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
25
|
10K
|
28
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Investor Presentation
|
|
snowunda
|
34 |
9.8K |
5 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
34
|
9.8K
|
5
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
snowunda
|
322 |
95K |
9 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
322
|
95K
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
snowunda
|
322 |
95K |
1 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
322
|
95K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics International seeks FDA approval for PromarkerD
|
|
snowunda
|
322 |
95K |
14 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
322
|
95K
|
14
|
|
ASX - By Stock
|
AVL |
Re:
Ann: Response to ASX Price and Volume Query
|
|
snowunda
|
12 |
9.9K |
23 |
19/01/21 |
19/01/21 |
ASX - By Stock
|
12
|
9.9K
|
23
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: AGM Investor Presentation
|
|
snowunda
|
22 |
5.9K |
7 |
26/11/20 |
26/11/20 |
ASX - By Stock
|
22
|
5.9K
|
7
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Middle East is next market for PromarkerD immunoassay test
|
|
snowunda
|
44 |
9.7K |
9 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
44
|
9.7K
|
9
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
snowunda
|
2 |
1.9K |
1 |
16/09/19 |
16/09/19 |
ASX - By Stock
|
2
|
1.9K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Adelaide Equity & Scintilla Capital appointed as advisors
|
|
snowunda
|
24 |
11K |
2 |
14/11/18 |
14/11/18 |
ASX - By Stock
|
24
|
11K
|
2
|
|
ASX - By Stock
|
MVL |
Re:
Ann: Graphex Agrees Funding Package to Fully Fund Chilalo
|
|
snowunda
|
23 |
11K |
1 |
29/10/18 |
29/10/18 |
ASX - By Stock
|
23
|
11K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics secures major contract - nears cash flow positive
|
|
snowunda
|
68 |
22K |
6 |
17/07/18 |
17/07/18 |
ASX - By Stock
|
68
|
22K
|
6
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs deal to launch PromarkerD test in US market
|
|
snowunda
|
15 |
6.4K |
4 |
28/05/18 |
28/05/18 |
ASX - By Stock
|
15
|
6.4K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Proteomics signs deal to launch PromarkerD test in US market
|
|
snowunda
|
15 |
6.4K |
8 |
28/05/18 |
28/05/18 |
ASX - By Stock
|
15
|
6.4K
|
8
|
|
ASX - By Stock
|
MVL |
Re:
Ann: Strong progress on feasibility study, EPC and offtake
|
|
snowunda
|
20 |
9.1K |
1 |
27/03/18 |
27/03/18 |
ASX - By Stock
|
20
|
9.1K
|
1
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Trading Halt
|
|
snowunda
|
6 |
3.7K |
4 |
10/06/17 |
10/06/17 |
ASX - By Stock
|
6
|
3.7K
|
4
|
|
ASX - By Stock
|
PIQ |
Re:
Ann: Appendix 3B
|
|
snowunda
|
5 |
1.9K |
0 |
20/04/17 |
20/04/17 |
ASX - By Stock
|
5
|
1.9K
|
0
|
|
ASX - By Stock
|
PIQ |
Re:
News: PIQ Proteomics international laboratories signs production contract with Monash Antibody...
|
|
snowunda
|
4 |
1.3K |
4 |
11/11/16 |
11/11/16 |
ASX - By Stock
|
4
|
1.3K
|
4
|
|
ASX - By Stock
|
AVL |
VRB ARTICLE from Canada
|
|
snowunda
|
7 |
2.3K |
9 |
14/04/16 |
14/04/16 |
ASX - By Stock
|
7
|
2.3K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
News: IMU Imugene Ltd updates on cancer immunotherapy product development
|
|
snowunda
|
26 |
5.6K |
2 |
07/03/16 |
07/03/16 |
ASX - By Stock
|
26
|
5.6K
|
2
|
|
ASX - By Stock
|
PIQ |
Re:
News: PIQ Proteomics International Laboratories says co remains in discussions for the...
|
|
snowunda
|
4 |
2.0K |
1 |
07/03/16 |
07/03/16 |
ASX - By Stock
|
4
|
2.0K
|
1
|
|
ASX - By Stock
|
CTP |
promising future ahead
|
|
snowunda
|
1 |
229 |
2 |
21/03/11 |
21/03/11 |
ASX - By Stock
|
1
|
229
|
2
|
|
Sport
|
|
Re:
going to melb cup
|
|
snowunda
|
21 |
402 |
0 |
03/05/10 |
03/05/10 |
Sport
|
21
|
402
|
0
|
|
ASX - By Stock
|
DTM |
all aboard!
|
|
snowunda
|
7 |
1.2K |
3 |
03/05/10 |
03/05/10 |
ASX - By Stock
|
7
|
1.2K
|
3
|
|